Based on our finding of the direct relationship between actin-containing ruffles and signaling active ErbB2 homodimers, it can be speculated that the combined inhibition of the actin network and ErbB2 dimers resembles a promising therapeutic approach in cancer therapy. The gene discussed is ERBB2; the disease is cancer.